Speakers

Rafiq Hasan

Chief Executive Officer • Complement Therapeutics

Rafiq has pursued a highly successful career in the pharma industry globally, including senior positions in ophthalmology with Bayer and Novartis. Most recently as SVP and Global Head of Ophthalmology at Bayer, Rafiq grew the business of Eylea® from launch to over USD 2.5bn in 5 years, including its launch in 5 indications in 3 years.

Also speaking

Lynn Fischer

Chief Executive Officer • TITLE21 Health Solutions

John Garcia

PhD, Head of New Manufacturing Technologies • UCL

Avencia Sanchez-Mejias

Co-Founder and Chief Executive Officer • Integra Therapeutics

Event Info

Image

Innovation Zone

Find out more about the Innovation Zone at Advanced Therapies Europe.
Image

Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.